We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ALMDP market cap is 1.9M. The company's latest EPS is EUR -0.8939 and P/E is -0.48.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 230k | 208k | 95k | 197k | 300k |
| Operating Income | -690k | -924k | -3.1M | -3.19M | -3.99M |
| Net Income | -1.93M | -791k | -2.65M | -2.75M | -3.96M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 719k | 837k | 4.33M | 1.92M | 1.93M |
| Total Liabilities | 3.14M | 2.92M | 2.68M | 2.97M | 6.43M |
| Total Equity | -2.42M | -2.08M | 1.65M | -1.06M | -4.5M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | N/A | N/A | N/A | N/A | N/A |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 1.9M |
| Price to Earnings Ratio | -0.48 |
| Price to Sales Ratio | 6.35 |
| Price to Cash Ratio | 46.24 |
| Price to Book Ratio | -0.42 |
| Dividend Yield | - |
| Shares Outstanding | 4.43M |
| Average Volume (1 week) | 31.4k |
| Average Volume (1 Month) | 26.93k |
| 52 Week Change | -51.14% |
| 52 Week High | 2.40 |
| 52 Week Low | 0.33 |
| Spread (Intraday) | 0.01 (2.33%) |
| Company Name | Medesis Pharma SA |
| Address |
l'oree des mas avenue du golf montpellier, herault 34670 |
| Website | https://www.medesispharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
